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Abstract: Several C2 symmetrical mixed tetraoxanes were prepared starting from a
gemdihydroperoxide and a ketone. The obtained tetraoxanes showed pronounced
antimalarial activity against P. falciparum chloroquine resistant W2 and chloro-
quine susceptible D6 strains, with N-(2-dimethylamino)ethyl-7,8,15,16-tetraoxa-di-
spiro5.2.5.2hexadecane-3-carboxamide being as active as artemisinin.
Keywords: mixed tetraoxane, malaria, Plasmodium falciparum, gem-dihydroperoxide.
INTRODUCTION
Malaria is a serious infectious disease affecting 300–500 million people per
year.1 The disease is caused by multiplication of the protozoan parasite Plasmo-
dium falciparum in erythrocytes. Increased resistance to standard, and affordable,
antimalarial drugs, such as chloroquine (CQ), further complicates the treatment of
infected individuals. The emergence of peroxide antimalarias of the 1,2,4-tri-
oxacyclohexane class (trioxanes), such as artemisinin and its derivatives, opened
new possibilities for treating the parasitemia. Another peroxide class of com-
pounds, 1,2,4,5-tetraoxacyclohexanes (tetraoxanes),2 has also proved to be effec-
tive antimalarials, although their pharmacological properties have been less ex-
plored than those of the trioxanes.
In addition to steroidal tetraoxanes, a significant number of dicyclohexylidene
tetraoxanes have been synthesised and their antimalarial activity evalueated in vi-
tro and in vivo.3 However, the structure of the previously evaluated dicyclohexyli-
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dene tetraoxanes was limited by the mode of their synthesis: only bis compounds
could be obtained directly from the corresponding ketones.4 Recent syntheses of
mixed tetraoxanes5,6 opened new possibilities for the controlled preparation of this
class of promising antimalarials.
In this paper, the synthesis and initial results of biological evaluation of mixed
tetraoxanes, derivatives of 7,8,15,16-tetraoxa-dispiro5.2.5.2hexadecane-3-car-
boxylic acid are reported. The present class of compounds was designed with the
aim of obtaining the simplest amphiphilic structures of C2 symmetry in an effort to
minimise the influence of steric effects of the tetraoxane antimalarials on their ac-
tivity, and to investigate the direct influence of various functionalities.
CHEMISTRY
Gem-dihydroperoxide 1 was obtained in 50 % yield from cyclohexanone us-
ing 30 % hydrogen peroxide and HCl as a catalyst. Compound 1 was identified by
comparison of its IR, 1H-NMR and 13C-NMR data7 to those of previously synthe-
sised gem-dihydroperoxides.5a The obtained gem-dihydroperoxide was coupled to
ketone 2 according to a recently developed procedure5a to yield the parent mixed
tetraoxane, methyl 7,8,15,16-tetraoxa-dispiro5.2.5.2hexadecane-3-carboxylate
(3) in 28 % yield. The identity of 3 was established from its spectral data.8 Using
the esteracidamide sequence (Scheme 1) desired amides were obtained in
68–80 % overall yield.
ANTIMALARIAL ACTIVITY
The tetraoxanes were screened against Plasmodium falciparum CQ resistant
W2 and CQ susceptible D6 strains following the protocol given in Ref. 2c. All the
synthesised tetraoxanes exhibited pronounced antimalarial activity. In accordance
with previous findings,2c the acid 4 was less active than the methyl ester 3, and sig-
nificantly less active than the corresponding amides 5–7 against both clones. Ac-
cording to a current hypothesis suggesting that peroxides exert their antimalarial
activity in the food-vacuole (FV) of P. falciparum at pH  5.5, amide 7, possessing
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Scheme 1.
an N,N-dimethylamino group, was designed in the expectation that protonation of
the basic nitrogen would mediate the efflux through the FV membranes, hence in-
creasing its concentration at the site of action. The in vitro antimalarial activity of
tetraoxane 7 (Table I) confirms our expectations, and the results of further in vitro
and in vivo screening will be reported in due time elsewhere.
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U ovom radu prikazana je sinteza serije C2 me{ovitih tetraoksana polaze}i od
gem-dihidroperoksida cikloheksanona. Dobijenim derivatima ispitana je in vitro aktiv-
nost prema W2 i D6 sojevima P. falciparum. Utvr|eno je da derivat N-(2-dimetilamino)e-
til-7,8,15,16-tetraoksa-dispiro5.2.5.2heksadekan-3-karboksamid pokazuje aktivnost vrlo
blisku aktivnosti poznatog antimalarika artemizinina.
(Primqeno 27. maja 2004)
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